glp 1 agonist medullary thyroid cancer GLP-1 Receptor Agonists and Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of thyroid GLP-1 Receptor Agonists & Thyroid

Conversely, abnormal blood glucose levels have been shown to elevate cancer risk and decrease survival rates in cancer patients [12, 50]

Side effects and safety profiles compared This is where the conversation gets complicated

Fineman MS, Bryant CLN, Colbert K, Jozefiak TH, Petersen JS, Horowitz M, et al

De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrm E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis

Proc Natl Acad Sci U S A (2020) 117(47):2995967